GENETIC AND EXPERIMENTAL STUDIES ON A LETHAL FACTOR (R) IN THE AXOLOTL WHICH INDUCES ABNORMALITIES IN THE RENAL SYSTEM AND OTHER ORGANS.

R. R. Humphrey

DOI: https://doi.org/10.1002/JEZ.1401550202

1964-03-01

The Journal of Experimental Zoology

Abstract:

What problem does this paper attempt to address?

Efficacy of Intra-Arterial Thrombolysis for Acute Central Retinal Artery Occlusion: A Meta-Analysis.

Haitao Hu,Bing Zhang,Yuqi Zhao,Huan Zhou,Hongfang Chen,Shenqiang Yan

DOI: https://doi.org/10.1159/000520443

IF: 2.4

2021-01-01

European Neurology

Abstract:Introduction: The best management strategy still remains strong controversy for acute nonarteritic central retinal artery occlusion (CRAO). We thus performed a meta-analysis to determine the efficacy of intra-arterial thrombolysis (IAT) for visual improvement according to different times from symptom onset. Methods: We searched EMBASE, PubMed, and Web of Science for relevant studies assessing efficiency of IAT in patients with CRAO compared with standard therapy. Fixed-effects and random-effects models were performed. Results: Five eligible studies including 459 patients with acute CRAO were pooled in the meta-analysis. In all, 219 (47.7%) received IAT, and the mean time from symptom onset to IAT was 13 h. The pooled analysis demonstrates odds ratio (OR) for the procedure of IAT and any visual improvement to be 1.520 (95% confidence intervals [CIs] 1.258–1.837; p < 0.001). Subgroup analyses further indicated that the CRAO patients who received IAT achieved any visual improvement more easily within 6 h from symptom onset (OR = 1.703, 95% CI 1.219–2.381; p = 0.002), but not those beyond 6 h (OR = 1.260, 95% CI 0.973–1.632; p = 0.080). Conclusion: Our meta-analysis of available published data supports IAT to be an alternative treatment option for CRAO patients within 6 h from symptom onset.
Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion

Yuta Takata,Yasuhito Nitta,Akio Miyakoshi,Atsushi Hayashi

DOI: https://doi.org/10.1159/000489696

2018-06-22

Abstract:Purpose: To report 2 cases of central retinal artery occlusion (CRAO) who underwent retinal endovascular surgery with injection of tissue plasminogen activator (tPA) into the retinal artery and showed a remarkable improvement in visual acuity and retinal circulation. Methods: Standard 25-G vitrectomy was performed under local anesthesia. Simultaneously, tPA (80,000 units/mL) solution was injected into the retinal artery of the optic disc for 2-3 min using a microneedle. Changes in visual acuity, fundus photography, optical coherence tomography (OCT), fluorescein angiography, and laser speckle flowgraphy (LSFG) results were examined. Results: Both cases could be treated within 12 h after the onset of CRAO. Case 1 was a 47-year-old woman. Her visual acuity improved from counting fingers before operation to 0.08 logMAR 1 month after the surgery. However, thinning of the retina at the macula was observed by OCT. Case 2 was a 70-year-old man. His visual acuity improved from counting fingers to 0.1 logMAR 2 months after the surgery. Both fluorescein angiography and LSFG showed improvement in retinal circulation after the surgery in case 2. Conclusions: Retinal endovascular surgery with injection of tPA into the retinal artery was feasible and may be a way to improve visual acuity and retinal circulation when performed in the acute phase of CRAO.
Acute central retinal artery occlusion treated with intravenous recombinant tissue plasminogen activator

Richard J Nowak,Hardik Amin,Kimberly Robeson,Joseph L Schindler

DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.01.003

Abstract:Central retinal artery occlusion (CRAO) causes ischemic stroke of the eye. We report a case of CRAO that was successfully treated with intravenous recombinant tissue plasminogen activator (rt-PA) and review the current literature. A 64-year-old right-handed man presented to the emergency department with acute left eye amaurosis. An ophthalmologic assessment revealed a left afferent pupillary defect, minimal visual acuity, macular edema with a cherry red spot, and multiple emboli in the inferotemporal arcade of the left eye. A neurologic examination was otherwise nonfocal; neuroimaging was normal. Acute CRAO was diagnosed, and rt-PA was administered intravenously 185 minutes after symptom onset. A repeat examination 4.5 hours after treatment found improved vision, reduced macular edema, and no emboli. An ophthalmologic evaluation 10 days later found a visual acuity of 20/200 in the left eye and bilateral arterial sclerosis without evidence of retinal emboli or macular edema. This case illustrates that intravenous rt-PA may be an effective therapeutic option for CRAO in select patients. Given the current literature and the recommended established safety window for thrombolytics in acute ischemic cerebral stroke, it is reasonable to administer intravenous treatment for CRAO within 4.5 hours after symptom onset. Nevertheless, it is critical that a prospective clinical trial confirm the efficacy, safety, and time window for treatment.
Midwifery and family practice.

A. Reid

1988-05-01

Abstract:With the release of the report of the Task Force on the Implementation of Midwifery in Ontario, in October 1987, it is clear that midwives will be legally practising in this province in the near future and probably, with time, in the rest of Canada also. Does this prospect pose a threat to family practitioners who wish to continue doing obstetrics? The author of this paper discusses the recommendations of the Task Force and argues that the introduction of midwifery should not be seen as representing competition for family physicians but as a positive step which may provide collaboration for low-risk maternity care. A number of models of co-operation are presented.
Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial

Celia S Chen,Andrew W Lee,Bruce Campbell,Tien Lee,Mark Paine,Clare Fraser,John Grigg,Romesh Markus

DOI: https://doi.org/10.1161/STROKEAHA.111.613653

IF: 10.17

Stroke

Abstract:Background and purpose: Central retinal artery occlusion is caused by a platelet-fibrin thrombus or embolic occlusion and is a stroke of the eye. Observational studies suggest that thrombolytics may restore ocular perfusion and visual function. We hypothesized that intravenous tissue-type plasminogen activator (tPA) administered within 24 hours of symptom onset might restore ocular perfusion and visual function. Methods: A placebo-controlled, randomized trial of intravenous tPA versus intravenous saline was performed in patients with clinically defined central retinal artery occlusion within 24 hours of symptom onset. tPA was administered at a total dose of 0.9 mg/kg, with 10% given as a 1-minute bolus and the remainder over 1 hour. An improvement of visual acuity of 3 lines or more was considered significant. Results: Twenty-five percent (2 of 8) of the tPA group experienced the primary outcome at 1 week after tPA versus none of the placebo group. One patient had an intracranial hemorrhage. The visual acuity improvement of these 2 patients was not sustained at 6 months. In both patients, tPA was administered within 6 hours of symptom onset. Conclusions: Although essentially a negative study, it does add to the evidence base of reperfusion in central retinal artery occlusion by showing that the time window for intervention is likely to be <6 hours. Reocclusion is a potential problem and may require adjuvant anticoagulation. Future studies should concentrate on determining the efficacy of thrombolytics in the <6-hour time window. Clinical Trial Registration- URL: http://www.anzctr.org.au. Unique identifier: 83102.
Observation on therapeutic efficacy of rt-PA intravenous thrombolysis combined with compound anisodine injection on central retinal artery occlusion

Xiao-Jun Wu,Feng Gao,Xu Liu,Qing Zhao

DOI: https://doi.org/10.3892/etm.2016.3681

Abstract:The aim of the present study was to observe the clinical efficacy and safety of recombinant tissue plasminogen activator (rt-PA) combined with compound anisodine in treating central retinal artery occlusion (CRAO). Forty-eight patients diagnosed with CRAO were randomly divided into a treatment group (24 cases) and a control group (24 cases). For the control group, nitroglycerin, 654-2, methazolamide, puerarin and compound anisodine were used for the treatment, along with oxygen, massage and other conventional treatments. Besides conventional therapy, the treatment group was also given intravenous rt-PA thrombolysis. Visual acuity, fundus oculi, visual field changes were taken as indicators for efficacy evaluation. It was found that the total effective rate of the control group was 70.83%, while that for the treatment group was 91.67%, and the comparative difference between the two groups was of statistical significance (p<0.05). The visual field defect of the control group after treatment was approximately 74.26±12.91%, and the visual field defect of the treatment group after treatment approximately 35.08±16.33%; thus, the comparative difference was statistically significant (p<0.01). The comparative difference of the original contents of fibrous protein in blood in the treatment group before and after treatment was statistically significant (p<0.01). In conclusion, the result show that intravenous thrombolysis with rt-PA combined with compound anisodine is safe and effective in treating CRAO, which can significantly improve the prognosis of patients.
Intra-retinal Arterial Cannulation using a Microneedle for Central Retinal Artery Occlusion

Kazuaki Kadonosono,Shin Yamane,Maiko Inoue,Tadashi Yamakawa,Eiichi Uchio

DOI: https://doi.org/10.1038/s41598-018-19747-7

2018-01-22

Abstract:Central retinal artery occlusion (CRAO) is a severe disease, often causing blindness. We evaluated the efficacy and safety of a surgical procedure for the treatment of acute CRAO in which retinal arterial cannulation with tissue plasminogen activator (tPA) is performed. The surgical procedure consisted of vitrectomy followed by cannulation of the central retinal artery and injection of tPA (200 μg) using a 47-gauge microneedle. Thirteen CRAO patients were treated within 48 hours of the onset of symptoms. The central retinal artery of all 13 eyes was successfully cannulated. The mean interval between the onset of symptoms and surgery was 38.7 hours. The results for all 13 eyes treated showed a statistically significant improvement in mean visual acuity between before and one month after treatment (-1.60 vs. -0.82 logarithmic values for minimum angle resolution (LogMAR), p = 0.0021). Fluorescein angiography showed complete reperfusion and incomplete reperfusion in 10 eyes and 3 eyes, respectively. Recently developed surgical instruments have made retinal-arterial cannulation feasible. Intra-retinal-arterial cannulation has potential as a method of improving visual function and microcirculation in eyes affected by CRAO.
Nationwide Incidence and Trends in Central Retinal Arterial Occlusion Management: A 5000-Patient Analysis

Galadu Subah,Patricia Xu,Sabrina Zeller,Bridget Nolan,Aiden Lui,Michael Fortunato,Eric Feldstein,Martin Kafina,Daniel Elefant,Ji Chong,Chirag Gandhi,Fawaz Al-Mufti

DOI: https://doi.org/10.1097/crd.0000000000000682

2024-04-26

Cardiology in Review

Abstract:Central retinal artery occlusion (CRAO) is a rare and visually debilitating vascular condition characterized by sudden and severe vision loss. CRAO is a compelling target for intravenous alteplase (tPA) and endovascular mechanical thrombectomy (MT) due to pathophysiological similarities with acute ischemic stroke; however, the utility of these interventions in CRAO remains dubious due to limited sample sizes and potential risks. To assess usage and outcomes of tPA and MT in CRAO, we queried the National Inpatient Sample database using International Classification of Disease, Ninth and Tenth edition for patients with CRAO and acute ischemic stroke between 2010 and 2019. Our cohort of 5009 CRAO patients were younger with higher rates of obesity, hypertension, long-term anticoagulant use, and tobacco use compared to acute ischemic stroke patients. CRAO patients had lower rates of tPA administration (3.41% vs 6.21%) and endovascular MT (0.38% vs 1.31%) but fewer complications, including deep vein thrombosis, pneumonia, urinary tract infection, acute kidney injury, and acute myocardial infarction (all P < 0.01). CRAO patients had lower rates of poor functional outcome (31.74% vs 58.1%) and in-hospital mortality (1.2% vs 5.64%), but higher rates of profound blindness (9.24% vs 0.58%). A multivariate regression showed no relationship between tPA and MT and profound blindness, although the limited sample size of patients receiving interventions may have contributed to this apparent insignificance. Further investigation of larger patient cohorts and alternative treatment modalities could provide valuable insights for revascularization therapies in CRAO to optimize visual restoration and clinical outcomes.

cardiac & cardiovascular systems
Scanning electron microscopic appearance of chronic ulcerative colitis with and without dysplasia.

H. Shields,M. Bates,H. Goldman,G. Zuckerman,B. Mills,C. J. Best,F. A. Bair,D. A. Goran,K. Deschryver‐Kecskemeti

DOI: https://doi.org/10.1016/0016-5085(85)90746-2

IF: 29.4

1985-07-01

Gastroenterology

Abstract:
[Disease profiling in haemato-oncology].

P. Huijgens

Tijdschrift voor Psychiatrie

Abstract:BACKGROUND In the field of haemato-oncology the staging of disease began in the 1960s with the mapping of the extent of a disease in order to create opportunities for effective local treatment. This led to the characterisation of cancer cells with the help of various techniques ranging from microscopy to the profiling of gene expression. AIM To provide an overview of staging and profiling in haematology. METHOD A description is given of the relevant methods and techniques and of the way in which these procedures are organised in the Netherlands. RESULTS In haematology it is essential to characterise an illness during diagnosis and during treatment. Slowly but surely protocols for estimating the severity of the patient’s disease and patient’s quality of life are being introduced. In the Netherlands the Dutch-Belgian Study Group for haemato-oncology for adults HOVON foundation) has been actively engaged for 25 years in integrating into one structure and one quality system the developments in disease profiling and the simultaneous improvements in treatment. CONCLUSION In the treatment of patients with a haematological malignancy it has become normal practice to characterise both the diseased cell and the extent of the illness during diagnosis and in the course of treatment. Improvements in characterisation and in treatment run parallel to each other and influence each other continuously. The HOVON foundation keeps a record of the results of each patient.
Vitrectomy and manipulation of intraocular and arterial pressures for the treatment of nonarteritic central retinal artery occlusion

Ogugua Ndubuisi Okonkwo,Adekunle Olubola Hassan,Toyin Akanbi,Victor Chukwuebuka Umeh,Oladapo Oluwadamilola Ogunbekun

DOI: https://doi.org/10.4103/tjo.tjo_51_20

2020-10-19

Abstract:The purpose of this study is to describe a surgical technique and report the functional outcome of treating nonarteritic central retinal artery occlusion (CRAO) in 2 eyes of two consecutive male patients. Two males (A) and (B) presented 6 days and few hours, respectively, after symptom onset with the clinical features typical of CRAO, including sudden severe deterioration of vision to counting fingers and a cherry-red spot in the left and right fovea, respectively. While A had been on recent treatment for hypertension and hyperlipidemia, B had no significant medical history. Both patients underwent surgery, A, 9 days, and B, <15 h after symptom onset. Surgery involved a vitrectomy, lowering of intraocular pressure (<3 mmHg), and gradual increase of arterial pressure to 165/100 mmHg (through the slow injection of intravenous adrenaline). Intraoperatively, this resulted in immediate perfusion and visible dilation of the blood-filled central retinal artery (CRA) and retinal arteriolar network and dilatation of the central retinal vein. The final vision settled to 6/60 in A and 6/36+1 in B. Although preoperative macular infarction persisted in both eyes as demonstrated by optical coherence tomography angiography, both patients claim a convincing subjective visual benefit. The procedure appeared to have positively changed the natural history of the disease in both eyes. Vitrectomy with the manipulation of intraocular and arterial pressures significantly increases ocular perfusion along the entire CRA, which can dislodge CRA thrombo-emboli and has the potential to restore retinal perfusion and improve visual outcome if undertaken before irreversible retina damage. This is a relatively straightforward technique and should join the list of surgical techniques for treating CRAO.
Visual Stimulation Rehabilitation for Cortical Blindness after Vertebral Artery Interventional Surgery: A Case Report and Literature Review

Juehan Wang,Liliang Zou,Xiaorui Jiang,Daming Wang,Lin Mao,Xiaofeng Yang

DOI: https://doi.org/10.1016/j.ijscr.2023.108753

2023-01-01

International Journal of Surgery Case Reports

Abstract:Introduction and importance: Cortical blindness (CB) after vertebral artery interventional surgery is not a frequently reported complication. In this study, the efficacy of visual stimulation rehabilitation consisting of visual recovery training and repetitive transcranial magnetic stimulation (rTMS) for cortical blindness was investigated by clinical evaluation, ophthalmologic examination, and electroencephalography (EEG).Case presentation: This study reports on a 55-year-old male who showed partial bilateral posterior cerebral artery cortical branch occlusion after timely embolectomy due to thrombus dislodgement during right vertebral artery opening, stenting resulting in basilar artery tip occlusion. The lesions were mainly located in the right cerebellar hemisphere and bilateral occipital lobes, and the patient suffered from bilateral loss of vision, with only light perception preserved. The patient began to receive visual recovery training and 15 sessions of right occipital high-frequency transcranial magnetic stimulation 5 days after the onset.Clinical discussion: After treatment, the patient's capacity to identify things improved, allowing him to watch television, as did the precision and fluency of random hand movements, walking, and self-care.Conclusion: Visual stimulation rehabilitation composed of visual recovery training and rTMS is a promising therapy option for cortical blindness, and our case report provides clinical experience with vision recovery for patients with cortical blindness.
Study of the efficacy of intravenous tissue plasminogen activator in central retinal artery occlusion

Celia S Chen,Andrew W Lee,Bruce Campbell,Mark Paine,Tien Lee,Clare Fraser,John Grigg,Romesh Markus,Keryn Williams,Doug J Coster

DOI: https://doi.org/10.1111/j.1747-4949.2010.00545.x

Abstract:Rationale: Central retinal artery occlusion is a stroke of the eye caused by a blockage of its main blood supply by platelet-fibrin clot. Systemic thrombolysis has been successful in restoring perfusion to ischaemic tissue by fibrin-platelet clot lysis in ischaemic stroke and myocardial infarction. Several open-label studies have demonstrated efficacy of thrombolysis in the treatment of central retinal artery occlusion, with up to 60-70% of treated subjects experiencing an improvement in visual acuity. Most of these are given intraarterially, which is an invasive procedure and not widely applicable to all treatment centres. An alternative is the intravenous infusion of tissue plasminogen activator using existing stroke thrombolysis protocols. A systematic review of all observational studies of intravenous tissue plasminogen activator in acute central retinal artery occlusion showed that 48·5% of subjects had a four line or more visual acuity improvement with an acceptable rate of haemorrhagic complications, creating the equipoise necessary to conduct a randomised controlled trial. Aim: To determine the efficacy of intravenous thrombolysis in acute treatment of central retinal artery occlusion. Design: A phase II, placebo-controlled, double-blind, randomised controlled trial comparing intravenous tissue plasminogen activator at 0·9 mg/kg to placebo (normal saline) 100 ml in a 1:1 block randomisation. Study outcome: The primary outcome measure is an improvement of three lines or more on the Snellen visual acuity chart, which signifies a doubling of the visual angle.
Fragments of MS2 RNA as messengers for specific bacteriophage proteins: fragments from fluorouracil-containing particles.

Y. Shimura,H. Kaizer,D. Nathans

DOI: https://doi.org/10.1016/0022-2836(68)90402-6

IF: 6.151

1968-12-28

Journal of Molecular Biology

Abstract:
An Evaluation Method for Content Analysis Based on Twitter Content Influence

Euijong Lee,Young-Gab Kim,Young-Duk Seo,Kwangsoo Seol,D. Baik

DOI: https://doi.org/10.1142/S0218194017500310

IF: 1.007

2017-06-01

International Journal of Software Engineering and Knowledge Engineering

Abstract:Twitter is a microblogging website, which has different characteristics from any other social networking service (SNS) in that it has one-directional relationships between users with short posts of less than 140 characters. These characteristics make Twitter not only a social network but also a news media. In addition, Twitter posts have been used and analyzed in various fields such as marketing, prediction of presidential elections, and requirement analysis. With an increase in Twitter usage, we need a more effective method to analyze Twitter content. In this paper, we propose a method for content analysis based on the influence of Twitter content. For measuring Twitter influence, we use the number of followers of the content author, retweet count, and currency of time. We perform experiments to compare the proposed method, frequency, numerical statistics, user influence, and sentiment score. The results show that the proposed method is slightly better than the other methods. In addition, we discuss Twitter characteristics and a method for an effective analysis of Twitter content.
Thrombolysis for Central Retinal Artery Occlusion in 2020: Time Is Vision!

Oana M Dumitrascu,Nancy J Newman,Valérie Biousse,Oana M. Dumitrascu,Nancy J. Newman

DOI: https://doi.org/10.1097/wno.0000000000001027

2020-07-30

Abstract:<span>Background: Acute nonarteritic central retinal artery occlusion (CRAO) is an eye stroke with poor visual prognosis and no proven effective therapies. Given advances in acute stroke care, thrombolysis in CRAO merits critical re-examination. We review the evidence for intravenous (IV) and intra-arterial (IA) tissue plasminogen activator (tPA) in CRAO management.Evidence Acquisition: MEDLINE, Scopus, and Cochrane online databases were systematically searched from 1960 to present, for reports of acute IV or IA therapy with alteplase or tenecteplase in nonarteritic CRAO patients. English language case reports, case series, interventional studies, or randomized controlled trials were included. The study type, age and number of subjects, the regimen administered, the time since symptoms' onset, visual outcome, and safety reports were noted.Results: Use of IV thrombolysis with alteplase was reported in 7 articles encompassing 111 patients, with 54% of them receiving IV tPA within 4.5 hours of symptom onset, and none developing symptomatic intracranial or ocular hemorrhage. Six studies described IA alteplase administration, with only 18 of a total of 134 patients (13.4%) treated within the first 6 hours after visual loss. The reported adverse events were minimal. Visual outcomes post-IV and IA thrombolysis were heterogeneously reported; however, most studies demonstrated benefit of the respective reperfusion therapies when administered very early. We found no reports of tenecteplase administration in CRAO.Conclusions: In 2020, nonarteritic CRAO patients should theoretically receive the same thrombolytic therapies, in the same time window, as patients with acute cerebral ischemia. Eye stroke and teleeye stroke code encounters must include an expert ophthalmologic evaluation to confirm the correct diagnosis and to evaluate for ocular signs that may help guide IV tPA administration or IA management. Future research should focus on developing feasible retinal penumbra imaging studies that, similar to cerebral tissue viability or perfusion imaging, can be incorporated into the thrombolysis decision-making algorithm.</span>

ophthalmology,clinical neurology
Webbasierte Suche in Vorlesungsvideos auf Basis der Transkripte eines Spracherkenners

Stephan Repp,A. Groß,C. Meinel

Abstract:An axle load-distributing apparatus includes an auxiliary frame having a load-distributing axle mounted thereon. The axle is supported by wheels which ultimately support a portion of the weight of a load carried on a load-carrying frame. An attachment device is provided for securing the frame to the load-carrying frame. An articulation device for providing articulation of the load-distributing axle relative to the load-carrying frame is provided as is a load distribution device which is operable to distribute a portion of the weight carried on the load-carrying frame to the load-distributing axle. The load distributing device is located intermediate of the attachment device and the articulation device.
Thrombolysis in acute retinal ischemia treated with tenecteplase

Sreevishnu Venkata Phanipawan Kalaga,Pramod Krishnan,Lakshmi Krupa A,Alfa Riyaz,Ramya Vemula

DOI: https://doi.org/10.5693/djo.02.2023.11.001

2024-04-05

Abstract:Central retinal artery occlusion (CRAO), a type of acute retinal arterial ischemia, analogous to an ocular stroke, is a medical emergency that warrants immediate diagnosis and treatment. CRAO usually presents with sudden, painless, monocular vision loss. Ipsilateral carotid artery disease is an important associated finding in these patients. The primary limitation to effective treatment of CRAO is that patients are rarely seen in the acute stage. Moreover, there are no guidelines for effective treatment. We report a patient with right CRAO whose treatment with intravenous thrombolysis with tenecteplase and anterior chamber paracentesis with ocular massage resulted in a good clinical outcome.
IV Thrombolysis for Central retinal artery occlusion – real-world experience from a Comprehensive Stroke Center

Christoph Stretz,John E Paddock,Tina M Burton,Tatiana Bakaeva,Melissa Freeman,Aparna Choudhury,Shadi Yaghi,Karen L Furie,Matthew Schrag,Brian C MacGrory

DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107610

IF: 2.677

2024-02-01

Journal of Stroke and Cerebrovascular Diseases

Abstract:Objectives Central retinal artery occlusion (CRAO) is a stroke of the retina potentially amenable to intravenous thrombolysis (IVT). We aimed to determine feasibility of an emergency treatment protocol and risk profile of IVT for CRAO in a comprehensive stroke center (CSC). Methods We performed a retrospective, observational cohort study including patients with acute CRAO admitted to a CSC over 4 years. Patients are offered IVT if they present with acute vision loss of ≤ 20/200 in the affected eye, have no other cause of vision loss (incorporating a dilated ophthalmologic exam), and meet criteria akin to acute ischemic stroke. We collected socio-demographic data, triage data, time from onset to presentation, IVT candidacy, and rates of symptomatic intracranial hemorrhage (sICH)- or extracranial hemorrhage. Results 36 patients presented within the study period, mean (standard deviation (SD)) age of 70.7 (10), 52% female, and median time (Q1, Q3) to ED presentation of 13.5 (4.3, 18.8) hours. Patients within 4.5 hours from onset presented more commonly directly to our ED (66.6% vs 37.1%, p = 0.1). Nine patients (25%) presented within the 4.5-hour window. Of those eligible, 7 (77%) received IVT. There were no events of intracranial or extracranial hemorrhage. Conclusions Our study confirmed that IVT for acute CRAO is feasible. We found a high rate of treatment with IVT of those eligible. However, because 75% of patients presented outside the treatment window, continued educational efforts are needed to improve rapid triage to emergency departments to facilitate evaluation for possible candidacy with IVT.

neurosciences,peripheral vascular disease
Thrombolysis in central retinal artery occlusion: a retrospective observational study

Florian Philipp Raber,Florian Vincent Gmeiner,Jens Dreyhaupt,Armin Wolf,Albert Christian Ludolph,Jens Ulrich Werner,Jan Kassubek,Katharina Althaus

DOI: https://doi.org/10.1007/s00415-022-11439-7

Abstract:Background: There is no evidence-based therapy for non-arteritic central retinal artery occlusion (NA-CRAO). Intravenous thrombolysis (IVT) with alteplase in a time window < 4.5 h may lead to a favorable outcome. Purpose of this study was to investigate the feasibility, efficacy and safety of IVT in patients classified as functionally blind. Methods: We conducted a retrospective observational study of NA-CRAO-patients. All patients underwent an ophthalmological and neurological examination including cerebral magnetic resonance imaging (MRI) for assessment of additional stroke lesions. Patients were treated either conservatively or with IVT within 4.5 h. Visual acuity (VA) was evaluated in logMAR and a categorical analysis was performed. Results: Thirty-seven patients were included in the study, 21 patients in the conservative treatment group (CTG) and 16 patients in the IVT group. The median logMAR visual acuity at admission and discharge was similar in both groups. The medium symptom to treatment time in the IVT group was 158.0 min. 3 patients (19%) of the IVT group showed a favorable outcome, all CTG patients remained at the level of functional blindness. No serious adverse events were observed after IVT. MRI showed additional acute stroke in over one-third of the patients (n = 14). Conclusions: Early intravenous thrombolysis therapy according to the current stroke protocol n a time window up to 4.5 h after the onset of symptoms was feasible and might be a potential treatment option for NA-CRAO. Patients with NA-CRAO are at very high risk of ischemic stroke and MRI should be done in all patients for optimized treatment and secondary stroke prevention. A prospective randomized study is required.

GENETIC AND EXPERIMENTAL STUDIES ON A LETHAL FACTOR (R) IN THE AXOLOTL WHICH INDUCES ABNORMALITIES IN THE RENAL SYSTEM AND OTHER ORGANS.

Efficacy of Intra-Arterial Thrombolysis for Acute Central Retinal Artery Occlusion: A Meta-Analysis.

Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion

Acute central retinal artery occlusion treated with intravenous recombinant tissue plasminogen activator

Midwifery and family practice.

Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial

Observation on therapeutic efficacy of rt-PA intravenous thrombolysis combined with compound anisodine injection on central retinal artery occlusion

Intra-retinal Arterial Cannulation using a Microneedle for Central Retinal Artery Occlusion

Nationwide Incidence and Trends in Central Retinal Arterial Occlusion Management: A 5000-Patient Analysis

Scanning electron microscopic appearance of chronic ulcerative colitis with and without dysplasia.

[Disease profiling in haemato-oncology].

Vitrectomy and manipulation of intraocular and arterial pressures for the treatment of nonarteritic central retinal artery occlusion

Visual Stimulation Rehabilitation for Cortical Blindness after Vertebral Artery Interventional Surgery: A Case Report and Literature Review

Study of the efficacy of intravenous tissue plasminogen activator in central retinal artery occlusion

Fragments of MS2 RNA as messengers for specific bacteriophage proteins: fragments from fluorouracil-containing particles.

An Evaluation Method for Content Analysis Based on Twitter Content Influence

Thrombolysis for Central Retinal Artery Occlusion in 2020: Time Is Vision!

Webbasierte Suche in Vorlesungsvideos auf Basis der Transkripte eines Spracherkenners

Thrombolysis in acute retinal ischemia treated with tenecteplase

IV Thrombolysis for Central retinal artery occlusion – real-world experience from a Comprehensive Stroke Center

Thrombolysis in central retinal artery occlusion: a retrospective observational study